Ma Qin, Guo Liang, Sun Jie, Fan Wen-Xi
Graduate School of Xinjiang Medical University, Urumqi 830011, China.
Yao Xue Xue Bao. 2013 Jan;48(1):77-82.
The starting material L-tryptophan reacted with 4-chlorobenzaldehyde via Pictet-Spengler condensation and followed by oxidation and decarboxylation to afford the 1-(4-chlorophenyl)-beta-carboline. The intermediate was further reacted with alkyl halogenide by N(9)-alkylation and N2-quaternarization to obtain 12 novel 1-(4-chlorophenyl)-beta-carboline derivatives. The chemical structures of all target compounds were characterized by elemental analyses, MS and 1H NMR spectra. The antitumor activities of the target compounds were evaluated by MTT method. The results demonstrated that N2-quaternarized compounds enhanced the antitumor activity significantly. In particular, compound 15 was found to be the most potent compound with IC50 values lower than 5 micromol x L(-1) against 6 human tumor cells. These results confirmed that the N2-alkyl or aralkyl substituent on the beta-carboline ring played an important role in the modulation of the antitumor activities.
起始原料L-色氨酸通过Pictet-Spengler缩合反应与4-氯苯甲醛反应,然后经过氧化和脱羧反应得到1-(4-氯苯基)-β-咔啉。中间体通过N(9)-烷基化和N2-季铵化进一步与卤代烷反应,得到12种新型的1-(4-氯苯基)-β-咔啉衍生物。所有目标化合物的化学结构通过元素分析、质谱和1H NMR光谱进行了表征。目标化合物的抗肿瘤活性通过MTT法进行评估。结果表明,N2-季铵化化合物显著增强了抗肿瘤活性。特别是,发现化合物15是最有效的化合物,对6种人类肿瘤细胞的IC50值低于5 μmol·L(-1)。这些结果证实,β-咔啉环上的N2-烷基或取代基在调节抗肿瘤活性中起重要作用。